Simoctocog alfa Not Yet Recruiting Phase 3 Trials for Hemophilia As Prevention

IndicationsStatusPurposePhase
Not Yet RecruitingPrevention3
clinicaltrials.gov IdentifierTitleDrugs
NCT04030052Emicizumab PUPs and Nuwiq ITI Study